Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 113

ОБЗОР2026 · pp. 79–86

Molecular mechanisms, pharmacological properties, and applications of PARP inhibitors in ovarian cancer therapy

Relevance. PARP inhibitors (PARPi), have emerged as a significant development in the treatment of high-grade serous ovarian cancer that is associated with mutations in BRCA1/2 and genes of other homologous recombination proteins. These drugs exploit synthetic …

10.29296/24999490-2026-03-11Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 53–58

Modern anticoagulants in the treatment and prevention of thrombotic complications in patients with Hodgkin’s lymphoma

Introduction. Cancer patients have a high risk of developing venous thromboembolic complications, which worsen the outcomes of antitumor treatment and are the second leading cause of death after cancer progression. Objectives – to assess the effect of modern a…

10.29296/24999490-2026-03-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 24–33

Transcription factors bioinformatic analysis of differential gene expression in b16 melanoma cells under antitumor alkylating agent application

Introduction. Cancer drug resistance is driven among others, by non-genetic mechanisms. These processes may involve transcription factors dysregulation, modifications in gene expression, as well as epigenetic mechanisms such as DNA methylation, histone modific…

10.29296/24999490-2026-03-04Details ↗
ОБЗОР2026 · pp. 75–83

Optimization of ctDNA and cfDNA detection: modern bioinformatic approaches to improve the accuracy of molecular diagnostics of tumors

Relevance. Modern approaches to detecting circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA) demonstrate high potential for improving the accuracy of molecular diagnostics of tumors and require a comprehensive analysis of all stages, from the biology of f…

10.29296/24999490-2026-02-10Details ↗
ОБЗОР2026 · pp. 80–88

Current advances in the study of molecular pathogenesis of breast cancer

Introduction. Breast cancer (BC) is a heterogeneous disease that represents a major global health problem. It is the most frequently diagnosed cancer in the world, with the incidence of breast cancer increasing year by year in most countries. The existence of …

10.29296/24999490-2026-01-10Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 58–69

Polypragmasy in elderly and senile patients with chronic kidney disease: START/STOP criteria in elderly and senile patients taking DOAC

Introduction. Thanks to the achievements of modern medicine, it was possible to significantly increase the life expectancy of the population. Molecular mechanisms of aging include telomere shortening, DNA damage accumulation, mitochondrial dysfunction, leading…

10.29296/24999490-2025-05-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 10–20

Biochemical markers of inflammation in drug-resistant tuberculous meningitis (experimental study)

Introduction. The determination of inflammatory markers used to monitor the course of the disease and monitor the effectiveness of treatment. Goal. To evaluate biochemical markers of inflammation in cerebrospinal fluid (CSF) and blood serum in experimental men…

10.29296/24999490-2025-05-02Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 3–9

Sirtuin expression in skin fibroblasts: pharmacomodulatory effect of quercetin

Introduction. Sirtuins (SIRTs) are NAD+-dependent histone deacetylases involved in the intracellular regulation of multiple biological processes including DNA repair, autophagy, inflammation, oxidative stress defence and metabolism associated with age-associat…

10.29296/24999490-2025-05-01Details ↗
ОБЗОР2025 · pp. 55–63

Neurotoxic complications of cancer chemotherapy

Introduction. Neurotoxicity is a common complication of chemotherapy that negatively affects the quality of life of cancer patients. Damage to the nervous system affects both the peripheral nerves (peripheral neuropathy) and the central nervous system (chemo b…

10.29296/24999490-2025-04-09Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 39–47

Ways to increase freedom from DOAC-dependent complications in elderly patients with polypharmacy and chronic kidney disease: molecular and genetic aspects

Introduction. Thanks to advances in modern medicine, it has been possible to significantly increase life expectancy. With the high effectiveness of methods for diagnosing and treating many chronic pathologies, a sharp increase in the number of elderly patients…

10.29296/24999490-2025-03-05Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 71–77

Study of the mutational landscape of primary foci and metastases of papillary carcinoma in the BRAF, KRAS and EGFR genes, their relationship with the clinical characteristics of the tumor

Introduction. Due to the rapidly growing incidence of tumor pathology of the thyroid gland, the range of molecular genetic research methods used to study the targets of targeted drugs, prognosis and surgical tactics is growing. Aim. To study the frequency of m…

10.29296/24999490-2025-02-09Details ↗
ОБЗОР2025 · pp. 21–31

Genome editing in neurodegenerative diseases: risk analysis, technological challenges, and prospects for clinical application

Objective. To analyze the potential risks and technological limitations of using genome editing methods in neurodegenerative diseases, as well as to assess the prospects for their implementation in clinical practice. Material and methods. A systematic analysis…

10.29296/24999490-2025-02-03Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 75–80

Genotoxic effect of SARS-CoV-2 on immunocompetent cells

Introduction. In present, the medical community continues to study the impact of coronavirus infection on various organs and systems of the body. Infection with the SARS-CoV-2 virus causes multifaceted pathological processes and, among other things, affects th…

10.29296/24999490-2024-06-09Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 57–64

The role of the AKT1 gene in the pathogenesis of type 2 diabetes mellitus and its complications

Introduction. Type 2 diabetes (T2D) is a chronic metabolic disorder. The number of diabetic people is increasing. AKT1 is a protein kinase and a participant in the PI3K/AKT/mTOR signaling pathway. The aim of the study was to analyze the association of polymorp…

10.29296/24999490-2024-03-09Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 45–52

Induction of hyperglycemia and accompanying biochemical and genotoxic changes in mice of different strains by tyloxapol

Introduction. Hyperglycemia inducers, the «classic» diabetogens streptozotocin and alloxan have a pronounced effect and are therefore limited suitable for modeling mild hyperglycemia in an experiment. Tyloxapol (Triton WR1339) was chosen as an alternative agen…

10.29296/24999490-2024-03-07Details ↗

Article search and quick navigation

Navigation